Related by context. All words. (Click for frequent words.) 75 Relapsing Multiple Sclerosis 75 Oral Fingolimod 74 efalizumab 74 Etanercept 74 Lenalidomide 74 Decitabine 73 teriflunomide 73 Nilotinib 73 Cimzia ® certolizumab pegol 73 glatiramer acetate 73 Pemetrexed 73 Dasatinib 73 Tocilizumab 73 Interferon Beta 73 Lubiprostone 73 relapsing multiple sclerosis 73 CIMZIA ™ 73 ORENCIA ® 73 Cardiotoxicity 72 Betaferon R 72 verteporfin 72 Adjuvant Treatment 72 salmeterol fluticasone 72 mycophenolate mofetil 72 metastatic malignant 72 Moxifloxacin 72 Adalimumab 72 FASLODEX 72 ritonavir boosted 72 Neulasta ® 72 Fulvestrant 72 adalimumab Humira 72 Interferon beta 1a 72 Naive Patients 72 Vidaza azacitidine 72 Pioglitazone 72 Safinamide 71 Traficet EN 71 Bortezomib 71 Fingolimod 71 ACTEMRA TM 71 Golimumab 71 Pegylated Interferon 71 PEGylated interferon beta 1a 71 SPRYCEL ® 71 Progressive Multifocal Leukoencephalopathy 71 LHRH agonists 71 AGILECT R 71 Laquinimod 71 Tiotropium 71 Acute Ischemic Stroke 71 Trastuzumab 71 Paraplatin ® 71 CIMZIA TM 71 CTAP# Capsules 71 Ranolazine 71 dual endothelin receptor antagonist 71 Pulmonary Arterial Hypertension 71 FOLFOX6 71 cinacalcet 71 PEGylated anti 71 Patients Receiving 71 recurrent glioblastoma multiforme 71 Relapsing Remitting Multiple Sclerosis 71 Capecitabine 71 Erlotinib 71 Doxil ® 71 gastrointestinal stromal tumors GIST 71 Teriparatide 71 Epirubicin 71 Mitoxantrone 71 Interferon beta 71 Antitumor Activity 71 Prolongs Survival 71 ZOLINZA 71 ACE Inhibitors 71 Anti TNF 71 sipuleucel T 71 AA Amyloidosis 71 STRIDE PD 71 Velcade bortezomib 71 thalidomide Thalomid 71 prucalopride 71 SYN# 71 boosted protease inhibitor 71 vidofludimus 71 ibandronate 71 TNF Tumor Necrosis Factor 70 Zorbtive TM 70 relapsed MM 70 rilonacept 70 biologic DMARD 70 complement inhibitor eculizumab 70 Keppra XR 70 HuMax CD4 70 oxaliplatin Eloxatin 70 Interferon beta 1b 70 Hydroxyurea 70 IFN beta 70 Valsartan 70 Gleevec imatinib mesylate 70 CIMZIA TM certolizumab pegol 70 r hGH 70 oral FTY# 70 RoACTEMRA 70 Peginterferon 70 CIMZIA R 70 ORENCIA R 70 infliximab Remicade 70 Tolvaptan 70 Allogeneic 70 corticosteroid dexamethasone 70 Nebulized 70 REYATAZ R 70 candesartan cilexetil 70 calcineurin inhibitor 70 GW# [003] 70 APTIVUS r 70 sitaxsentan 70 Randomized Phase 70 Vandetanib 70 relapsing remitting MS RRMS 70 Cilostazol 70 Metastatic Prostate Cancer 70 YONDELIS 70 Newly Diagnosed Multiple Myeloma 70 pioglitazone HCl 70 DOXIL 70 Renal Cell Carcinoma 70 Diabetic Neuropathy 70 etanercept Enbrel 70 Tesamorelin 70 Raptiva ® 70 Pegylated Liposomal Doxorubicin 70 Pharmacokinetics PK 70 Dacogen decitabine 70 Bevacizumab 70 selective modulator 70 Androxal TM 70 Bosentan 70 abacavir Ziagen 70 VAPRISOL 70 alteplase 70 Follicular Lymphoma 70 ATACAND 70 haematologic 70 Kepivance 70 Rotigotine 70 Boceprevir 70 vorinostat 70 Meets Primary Endpoint 70 Danazol 69 Advanced Renal Cell 69 See CLINICAL PHARMACOLOGY 69 PEG IFN 69 Certolizumab pegol 69 MYCAMINE 69 natalizumab 69 Temsirolimus 69 MGd 69 Candesartan 69 Rituximab 69 desvenlafaxine succinate 69 Aliskiren 69 Granulocyte Colony Stimulating Factor 69 Neoadjuvant 69 Antiviral Therapy 69 Betaferon ® 69 malignant ascites 69 Irinotecan 69 erlotinib Tarceva ® 69 Monotherapy 69 Intravitreal 69 Degarelix 69 psoriatic arthritis PsA 69 nephrotoxicity 69 Mycophenolate Mofetil 69 terlipressin 69 Tigecycline 69 SPIRIVA ® 69 PEGylated Fab fragment 69 novel VDA molecule 69 ULORIC 69 Allergic Rhinitis 69 Myelodysplastic Syndrome MDS 69 Anthracycline 69 Mg Uk 69 Severe Sepsis 69 paricalcitol 69 Mg Usa 69 SNT MC# 69 Glatiramer Acetate 69 Interferon alpha 69 Bazedoxifene 69 Rebif ® 69 metastatic neuroendocrine tumors 69 Hormone Refractory Prostate Cancer 69 alfa 2a 69 trabectedin 69 IV Busulfex 69 Long Term Efficacy 69 leukotriene receptor antagonist 69 Fondaparinux 69 Recombinant Human 69 rFVIIa 69 PegIFN RBV 69 ximelagatran 69 Microplasmin 69 immunomodulatory therapy 69 primidone 69 trastuzumab Herceptin ® 69 evaluating tivozanib 69 Complicated Skin 69 somatostatin analog 69 Fludarabine 69 clodronate 69 Alemtuzumab 69 RAPTIVA 69 Romiplostim 69 systemic corticosteroid 69 pegylated liposomal doxorubicin 69 Hycamtin ® 69 Camptosar ® 69 ara C 69 Relapsed Multiple Myeloma 69 TEMODAL 69 Ramipril 69 GAMMAGARD 69 Vaprisol 69 tigecycline 69 Catena ® 69 Raptiva R 69 Gemcitabine 69 Tacrolimus 69 PRISTIQ 69 Patients Treated With 69 STELARA TM 69 Adjunctive 69 thetreatment 69 Zarnestra 69 Lamotrigine 69 Previously Treated 69 Cimzia TM 69 Amrubicin 69 HoFH 69 AZILECT ® 69 INVEGA ® 69 Bezielle 69 ARIXTRA 69 paroxetine Paxil 69 efavirenz EFV 69 A1PI 69 PSMA ADC 69 tenofovir emtricitabine 69 Glypromate 69 Adefovir 69 relapsed ovarian cancer 69 adriamycin 69 Melphalan 69 nucleoside analog 69 virological response 69 xanthine oxidase inhibitor 69 interferon beta therapy 69 angiotensin receptor blocker ARB 69 HMG CoA reductase inhibitors 69 Castration Resistant Prostate Cancer 68 Omalizumab 68 Peginterferon alfa 2b 68 diarrhea predominant irritable 68 meropenem 68 Parathyroid Hormone 68 IFN α 68 aspirin clopidogrel 68 mitoxantrone plus 68 ACEIs 68 Myelofibrosis 68 ATL/TV# 68 Filgrastim 68 interferon gamma 1b 68 tipranavir 68 Vfend 68 Oxaliplatin 68 trimethoprim sulfamethoxazole 68 Gleevec resistant 68 myelodysplastic myeloproliferative diseases 68 esophageal candidiasis 68 azacytidine 68 Phase 2a Clinical Trial 68 mycophenolate mofetil MMF 68 octreotide acetate 68 Desmopressin 68 Overactive Bladder 68 protease inhibitors PIs 68 calcineurin inhibitors 68 INCB# [003] 68 Hypercholesterolemia 68 Hepatocellular Carcinoma 68 Novel Oral 68 Myelodysplastic Syndromes 68 oxcarbazepine 68 oral rivaroxaban 68 BARACLUDE ® 68 leukemia AML 68 Tasigna nilotinib 68 pamidronate 68 riociguat 68 AZILECT R 68 Azilect ® 68 divalproex sodium 68 Platinol ® 68 rFSH 68 Unfractionated Heparin 68 invasive candidiasis 68 CAELYX 68 Eculizumab 68 Xelox 68 ACZ# 68 Aptivus ® 68 Dalbavancin 68 SEROQUEL R 68 cidofovir 68 FUSILEV enhances 68 oral prodrug 68 NMDA antagonist 68 levocetirizine 68 dexamethasone Decadron 68 Diabetic Nephropathy 68 icatibant 68 Novantrone 68 Intravesical 68 steroid dexamethasone 68 immunosuppressant drug 68 MoxDuo IR 68 Angiotensin Converting Enzyme 68 Fluconazole 68 Helicobacter pylori eradication 68 Azacitidine 68 Sipuleucel T 68 AGILECT ® 68 LYSTEDA 68 Raltegravir 68 β blockers 68 ACE Inhibitor 68 hyperphenylalaninemia HPA due 68 hypereosinophilic syndrome 68 LEUKINE 68 CsA 68 Paliperidone ER 68 pomalidomide 68 vapreotide acetate 68 goserelin 68 Gastrointestinal Stromal Tumors 68 briakinumab 68 Fludara ® 68 Double Blind Randomized 68 alpha blocker 68 Malignant Glioma 68 Losartan 68 Adjuvant Therapy 68 sertraline Zoloft 68 Rheumatoid 68 rituximab Rituxan 68 tocilizumab 68 Tolerability 68 decitabine 68 zoledronate 68 Eltrombopag 68 pegfilgrastim 68 Avastin bevacizumab 68 HCV Genotype 68 MEVACOR 68 rufinamide 68 trastuzumab Herceptin 68 Prospective Randomized 68 enalapril 68 chronic eosinophilic leukemia 68 sorafenib Nexavar 68 NATRECOR ® 68 idraparinux 68 beta 1a 68 Abacavir 68 Roche Actemra 68 Ranibizumab 68 Pooled Analysis 68 steroid refractory ulcerative 68 Enzastaurin 68 tiuxetan 68 NAVISTAR R 68 Carvedilol 68 Immunosuppression 68 Pertuzumab 68 Shows Efficacy 68 levodopa therapy 68 PAOD 68 DEXILANT 68 MAGE A3 ASCI 68 antiarrhythmic drug 68 sorafenib tablets 68 intravenous immunoglobulin IVIg 68 Metastatic Renal Cell Carcinoma 68 Advagraf 68 Bosutinib 68 HuMax EGFr 68 Treated Patients 68 Vimpat R 68 CYT# potent vascular disrupting 68 Anti VEGF 68 Plaque Psoriasis 68 pharmacokinetic interactions 68 thromboembolic disease 68 HeFH 68 CANCIDAS 68 Cimzia ® 68 anakinra 68 aripiprazole Abilify 68 Zoledronic acid 68 Amgen Neulasta R 68 Noxafil 68 mometasone furoate 68 APTIVUS 68 Privigen 68 Neovascular Age Related Macular 68 fluvastatin 68 Relapsed Refractory 68 Advanced Melanoma 68 Alvesco R 68 AZT zidovudine Retrovir 68 Critical Limb Ischemia CLI 68 Hyperlipidemia 68 Well Tolerated 68 abacavir lamivudine 68 Antitumor 68 pancreatic insufficiency 68 peritumoral brain edema 68 miconazole Lauriad ® 68 Chemoradiation 67 TMC# r 67 alefacept 67 hepatorenal syndrome 67 adalimumab 67 antiplatelet agent 67 Vidofludimus 67 Fluticasone 67 humanized interleukin 6 67 8mg/kg 67 Antiangiogenic 67 AVONEX ® 67 Aflibercept 67 Aloxi injection 67 Serdolect ® 67 FIRMAGON 67 Bicalutamide 67 Lymphocytic 67 gemcitabine Gemzar 67 Budesonide 67 Corticosteroids 67 herpetic keratitis 67 Ganciclovir 67 Sprycel dasatinib 67 Is Well Tolerated 67 Pivotal Phase 67 Benign Prostatic Hyperplasia 67 hA# 67 Lupus Nephritis 67 clomipramine 67 JAK Inhibitor 67 Certolizumab 67 Chronic Heart Failure 67 Protease Inhibitors 67 Calcitonin 67 Bendamustine 67 clobazam 67 INTEGRILIN R 67 Metastatic Melanoma 67 visilizumab 67 antimuscarinic 67 CIPN 67 Copegus ribavirin 67 Adjunctive Therapy 67 Demonstrates Significant 67 brand ciclesonide HFA 67 Atypical Hemolytic Uremic Syndrome 67 Dapagliflozin 67 glatiramer 67 zidovudine AZT 67 Placebo Controlled Study 67 Infliximab 67 Autologous Stem Cell Transplantation 67 Epoetin Alfa 67 Ischemic 67 Sanvar R 67 antifibrinolytic 67 Posaconazole 67 Hsp# Inhibitor 67 Soft Tissue Sarcoma 67 pegaptanib 67 conventional DMARDs 67 chronic thromboembolic pulmonary 67 Atomoxetine 67 mycophenolic acid 67 inhibitor RG# 67 Alkeran 67 Torisel 67 methylnaltrexone bromide 67 PKC# 67 immunomodulatory agents 67 SHPT 67 dasatinib Sprycel 67 assessing T DM1 67 LHRH agonist 67 Phase III Clinical Trial 67 Didanosine 67 aldosterone antagonists 67 Rheumatoid Arthritis RA 67 RAPAFLO 67 Archexin 67 alkylating agent 67 TREDAPTIVE 67 Neupro R 67 recombinant tissue plasminogen 67 Bronchiectasis 67 Sitagliptin 67 Quetiapine 67 HER2 overexpression 67 4mg/kg 67 Tumor Response 67 pyrazinamide 67 rosuvastatin #mg 67 anti androgen 67 fluticasone salmeterol 67 allogeneic HSCT 67 Sandostatin R 67 Cimzia R 67 Cyclosporine 67 COPAXONE R 67 interferon ribavirin 67 deferiprone 67 Azathioprine 67 Maribavir 67 Glufosfamide 67 oral antidiabetic medication 67 Efficacy Trial 67 forodesine 67 Intravenous immunoglobulin 67 chronic idiopathic thrombocytopenic purpura 67 Elitek 67 epoprostenol 67 diabetic gastroparesis 67 Cutaneous T 67 Kinoid 67 Tekamlo 67 Ramelteon 67 indinavir 67 Pegloticase 67 Phase 2b Clinical Trial 67 MYLOTARG 67 NMIBC 67 galiximab 67 Dabigatran etexilate 67 basiliximab 67 liposomal amphotericin B 67 AMEVIVE 67 Pazopanib 67 venlafaxine Effexor 67 pan HDAC inhibitor 67 romiplostim 67 long acting bronchodilator 67 clopidogrel Plavix 67 protease inhibitor PI 67 pyridostigmine 67 rotigotine 67 Abatacept 67 Placebo Controlled Trial 67 tafamidis 67 Triapine R 67 Levodopa 67 cis retinoic acid 67 CYP#A# substrate 67 levodopa carbidopa 67 sargramostim 67 cilostazol 67 adefovir dipivoxil 67 Lysteda 67 Itraconazole 67 antithrombotics 67 XYOTAX TM 67 Ocrelizumab 67 budesonide foam 67 Leukemias 67 EXJADE 67 lenalidomide Revlimid R 67 Renal Function 67 antitumor efficacy 67 interleukin IL -# 67 cediranib 67 Hepatotoxicity 67 olmesartan 67 Rheumatoid Arthritis Patients 67 efaproxiral 67 TYKERB 67 Tasimelteon 67 recurrent genital herpes 67 IRESSA 67 Study Evaluating 67 Hormone Receptor Positive 67 radiotherapy RT 67 pimecrolimus 67 hour bronchodilation 67 Cloretazine 67 Warfarin Coumadin 67 Carbidopa 67 tipranavir r 67 Chronic Hepatitis C 67 IL 1ß 67 caspofungin 67 idiopathic thrombocytopenic purpura ITP 67 refractory gout 67 anagrelide 67 Survival Benefit 67 Imiquimod 67 Medoxomil 67 Pivotal Phase III 67 diabetic kidney 67 brivaracetam 67 intravesical infusion therapy 67 VFEND 67 Tanespimycin 67 TMP SMX 67 canakinumab 67 HMG CoA reductase inhibitor 67 unfractionated heparin UFH 67 elotuzumab 67 bevacizumab Avastin 67 Fibrillex TM 67 Ivabradine 67 Anastrozole 67 APTIVUS R 67 metastatic castration resistant 67 Voreloxin 67 Topiramate 67 EDARBI 67 Idiopathic Pulmonary Fibrosis 67 Combination therapy 67 SGPT 67 REMINYL ® 67 ZYVOX 67 inotropic 67 MULTAQ 67 dihydrochloride 67 standard chemotherapy regimen 67 metformin sulfonylurea 67 HBeAg positive patients 67 octreotide LAR 67 Clinical Trial Results 67 Dose Escalation 67 Thrombin 67 Etravirine 67 Factor VIIa 67 secondary hyperparathyroidism 67 Femara letrozole 67 Donepezil 67 Antiplatelet 67 endometrial hyperplasia 67 PROCRIT ® 67 certolizumab 67 interferon beta 1b 67 ZACTIMA 67 MS relapses 67 prednisone prednisolone 67 tolterodine ER 67 tegaserod 67 Gleevec Glivec 67 tibolone 67 Chronic HCV 67 tumor necrosis 67 Pivotal Clinical Trial 67 candidemia 67 guanfacine extended release 67 Esomeprazole 67 alfuzosin 67 BENICAR HCT 67 Teriflunomide 67 Cyclooxygenase 2 67 Interferon alfa 66 chemoradiation therapy 66 Chronic Sinusitis 66 Gamunex C 66 BRIM2 66 phase IIb trial 66 PROMACTA 66 liposomal formulation 66 Olmesartan 66 mertansine 66 Panzem R 66 Angioedema 66 daunorubicin 66 Epidermal Growth Factor Receptor 66 sJIA 66 idarubicin 66 TYSABRI natalizumab 66 interferon IFN 66 CHOP chemotherapy 66 protein tyrosine phosphatase 1B 66 BANZEL 66 Herceptin trastuzumab 66 amifostine 66 p# biomarker 66 chemoradiotherapy 66 Clostridium difficile Infection 66 myopathy rhabdomyolysis 66 IRX 2 66 rasagiline tablets 66 atazanavir sulfate 66 gastrointestinal GI motility disorders 66 ALGRX 66 docetaxel Taxotere ® 66 postoperative ileus 66 paclitaxel Taxol R 66 dopamine receptor agonist 66 Tarceva TM 66 delafloxacin 66 Fluorouracil 66 serum phosphate 66 Bivalirudin 66 PEGylated interferon 66 Systemic Lupus Erythematosus 66 INFERGEN 66 Hepatitis C Genotype 66 RhuDex ® 66 Sevelamer 66 Lansoprazole 66 Arikace 66 Ziprasidone 66 interleukin IL -6 66 Improved Survival 66 tamoxifen Nolvadex ® 66 FROVA 66 mu opioid receptor antagonist 66 Aviptadil 66 INCB# [001] 66 Ketorolac 66 Adult Stem Cell Therapy 66 TH# [003] 66 dose cohort 66 Carbamazepine 66 BAL# [002] 66 dopamine partial agonist 66 Galantamine 66 bisoprolol 66 R Saizen R 66 IFN alfa 66 doxazosin 66 Diabetic Macular Edema 66 Advanced Colorectal Cancer 66 Thalomid ® 66 TMS Therapy 66 FAMPYRA 66 tumor xenograft models 66 SCIg 66 Xeloda ® 66 Actemra tocilizumab 66 Dual Opioid 66 vWF 66 Telbivudine 66 Tumor Necrosis Factor 66 zonisamide SR 66 metastatic malignant melanoma 66 ELACYT 66 Vildagliptin 66 Clinical Outcome 66 Treatment Regimen 66 Relapsed Refractory Multiple Myeloma 66 acute GvHD 66 Thal Dex 66 GnRH agonist 66 levetiracetam Keppra 66 platelet inhibitor 66 5 Fluorouracil 66 PsA 66 Interferon Alfa 66 BARACLUDE R 66 biliary tract cancer 66 Telmisartan 66 H2 antagonists 66 hypercholesterolaemia 66 Darunavir 66 Exemestane 66 conjugated estrogens 66 vandetanib 66 sunitinib Sutent ® 66 Orally administered 66 receptor blocker 66 Crestor rosuvastatin 66 II Clinical Trial 66 epoetin alpha 66 R lenalidomide 66 irbesartan 66 metaglidasen 66 Crohn disease CD 66 interferon beta 1a 66 Topotecan 66 Neupogen ® 66 haloperidol Haldol 66 rhIGF-I/rhIGFBP-3 66 mRCC 66 Hypotension 66 Levoleucovorin 66 receptor tyrosine kinase inhibitor 66 antimetabolite 66 relapsed multiple myeloma 66 LymphoStat B belimumab 66 erlotinib Tarceva 66 metastatic hormone refractory 66 GnRH agonists 66 invasive aspergillosis 66 LAB CGRP 66 DAVANAT 66 Chemokine Receptor 66 Gemzar ® 66 Tyrosine Kinase Inhibitor 66 PRT# 66 vinca alkaloid 66 Solid Tumors 66 Oral Formulation 66 Perindopril 66 DFMO 66 Estrogen Receptor 66 PROCHYMAL 66 R#/MEM 66 nadolol 66 Ambrisentan 66 Dacogen injection 66 NOXAFIL 66 Enzyme Replacement Therapy 66 agomelatine 66 Thrombotic 66 Folfox 66 thiazide diuretic 66 Mirapexin 66 Protease Inhibitor 66 RhuDex 66 Effexor venlafaxine 66 acyclovir Lauriad R 66 gefitinib Iressa 66 Levofloxacin 66 bezafibrate 66 Epratuzumab 66 Dabigatran 66 inhaled iloprost 66 cannabinor 66 denileukin diftitox 66 baminercept 66 ALA PDT 66 vWD 66 fosamprenavir 66 #mg BID [001] 66 Cystatin C 66 FTY# 66 sunitinib malate 66 TNF alpha antagonist 66 Indomethacin 66 hematological parameters 66 J Am Coll 66 TO AVOID PREGNANCY WHILE 66 Inhalation Aerosol 66 systemic antifungal 66 Neurodex 66 vinorelbine tartrate 66 Valacyclovir 66 ancrod 66 Glatiramer acetate 66 palifermin 66 Improves Outcomes 66 cisplatin chemotherapy 66 inhaled corticosteroid ICS 66 Taxotere docetaxel 66 Ecallantide 66 Inhalation Solution 66 RezularTM 66 alpha 2a 66 somatostatin analogues 66 tanespimycin 66 combination antiretroviral therapy 66 Glivec imatinib 66 Pregabalin 66 antithrombotic 66 IMiDs ® 66 nucleotide analog 66 Squalamine 66 symptomatic intracranial 66 serum urate levels 66 Virologic 66 Fabry Disease 66 metastatic CRC 66 Phase 2b Trial 66 Prilosec omeprazole 66 Chronic Prostatitis 66 colorectal adenoma 66 nonnucleoside reverse transcriptase inhibitors 66 ARCOXIA 66 Disease Progression 66 Xanafide 66 HER2 Positive Breast Cancer 66 posaconazole 66 angiotensin converting enzyme inhibitor 66 Treatment Naive Patients 66 hyperplasia BPH 66 quetiapine Seroquel 66 flutamide 66 rotigotine transdermal patch 66 fluorouracil leucovorin 66 TORISEL 66 Treatment Resistant 66 hematologic parameters 66 gemcitabine Gemzar ® 66 Bucindolol 66 DDP# 66 antitumor effect 66 Demonstrates Potent 66 relapsing remitting multiple sclerosis 66 cetuximab Erbitux R 66 bronchial hyperresponsiveness 66 oral diclofenac 66 Antiviral Activity 66 Trabectedin 66 TRAIL R1 66 tipranavir ritonavir 66 GLIADEL R Wafer 66 SELZENTRY 66 amphotericin B 66 generation purine nucleoside 66 Pegylated interferon 66 Systemic Sclerosis 66 MabThera Rituxan 66 Immunotherapeutic 66 intermittent dosing 66 Interferon Alpha 66 Tipranavir 66 Lipodystrophy 66 Zenapax 66 antiplatelet therapies 66 Peginterferon Alfa 2a 66 Immunosuppressant 66 Elderly Patients 66 corticosteroid dose 66 Controlled Trial 66 lipid lowering agents 66 thrombolytics 66 methylnaltrexone 66 IMiDs ® compound 66 lumiliximab 66 metastatic gastric 66 ADPKD 66 bendamustine 66 estramustine 66 Octreotide 66 LAF# 66 Riluzole 66 Ticagrelor 66 imatinib Gleevec ® 66 Anticonvulsants 66 anticholinergic agents 66 abatacept Orencia 66 fibrinolytic 66 nitrofurantoin 66 Phase IIb Trial 66 Demonstrate Significant 66 VELCADE melphalan 66 tumor lysis syndrome 66 interferon therapy 66 Pirfenidone 66 Enoxaparin 66 LIVALO 66 TRO# 66 subcutaneously administered 66 Combination Therapy 66 hylan GF 66 Ropinirole 66 Patients Treated 66 2 methoxyestradiol 66 moderate renal impairment 66 Initiate Clinical Trial 66 lenalidomide dexamethasone 66 Alequel 66 Initiate Phase 66 hormone agonist 66 active ankylosing spondylitis 66 induced macular edema 66 #mg/day [002] 66 Liprotamase 66 tacrolimus ointment 66 oral antidiabetic 66 Mouse Model 66 CellCept mycophenolate mofetil 66 induce orthostatic hypotension 66 Daptomycin 66 colorectal liver metastases 66 Generalized Anxiety Disorder 66 desvenlafaxine